Importantly, the results of CHIP-qPCR assays certify that KDM4D interacts with the JAG1 promoter, which means KDM4D can transcriptionally activate JAG1 and promote ccRCC angiogenesis and development. This evidence concerns the gene JAG1 and nonpapillary renal cell carcinoma.